Regulating for Competition
Seiten
1990
Clarendon Press (Verlag)
978-0-19-827570-1 (ISBN)
Clarendon Press (Verlag)
978-0-19-827570-1 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
This study of one the most closely regulated sectors of the Western economies analyzes the regulatory systems of France and the UK, with particular emphasis on safety, control of price and profit, and promotional restrictions.
The pharmaceutical industry is one of the most closely regualted sectors of the Western economies. In this book, Leigh Hancher analyzes the regulatory systems in France and the UK, with particular emphasis on safety, control of price and profit, and promotional restrictions. She examines in detail the laws on competition and intellectual property as they affect the industry and traces the impact of European law and policy on these different regulatory controls, describing the manner in which national legislators and policy-makers are constrained by EC law. Dr Hancher offers an analysis of regulation as a dynamic process. She explores its impact on the operating environment of major research-based firms and compares the ways in which different legal cultures may provide different opportunities or impose different forms of constraint on policy makers. Her study gives a comprehensive overview of the laws governing competition and intellectual property in France and the UK.
The pharmaceutical industry is one of the most closely regualted sectors of the Western economies. In this book, Leigh Hancher analyzes the regulatory systems in France and the UK, with particular emphasis on safety, control of price and profit, and promotional restrictions. She examines in detail the laws on competition and intellectual property as they affect the industry and traces the impact of European law and policy on these different regulatory controls, describing the manner in which national legislators and policy-makers are constrained by EC law. Dr Hancher offers an analysis of regulation as a dynamic process. She explores its impact on the operating environment of major research-based firms and compares the ways in which different legal cultures may provide different opportunities or impose different forms of constraint on policy makers. Her study gives a comprehensive overview of the laws governing competition and intellectual property in France and the UK.
The legal context of government-industry relations; the economics of the pharmaceutical industry; post-war price control; evolving patterns of institutionalization; drug safety and drug marketing; the impact of European law and policy; cost control in the 1980's - reappraising health costs in the UK; cost control and contracts - the French experiment; regulating pharmaceutical promotion - an impossible task?; competition law and policy - an alternative strategy?; regulating for competition - an impossible goal?
| Erscheint lt. Verlag | 1.12.1990 |
|---|---|
| Zusatzinfo | tables, bibliography |
| Verlagsort | Oxford |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Recht / Steuern ► EU / Internationales Recht | |
| Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht | |
| Recht / Steuern ► Wirtschaftsrecht ► Wettbewerbsrecht | |
| Technik | |
| ISBN-10 | 0-19-827570-6 / 0198275706 |
| ISBN-13 | 978-0-19-827570-1 / 9780198275701 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
mit Auszug aus der StrlSchV : Kommentar
Buch | Hardcover (2025)
C.H.Beck (Verlag)
CHF 348,55
